Physician profile
Daniel C Brown
NPI 1063917045
$543.30
in general payments reported to CMS, 2019-2025
13 companies · $503 in 2025
The $503 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $22.41 · 2024: $18.16 · 2025: $503.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $192.72 | 2025 | Omnipod, Omnipod |
| Beta Bionics, INC. | $62.59 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Lilly USA, LLC | $41.54 | 2025 | Zepbound, Mounjaro, Jardiance |
| Madrigal Pharmaceuticals | $41.48 | 2025 | Rezdiffra |
| Tandem Diabetes Care, INC. | $37.35 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $32.45 | 2025 | Cequr Simplicity |
| Kyowa Kirin, INC. | $27.33 | 2025 | |
| Pharming Healthcare, INC. | $22.41 | 2023 | Ruconest |
| Xeris Pharmaceuticals, INC. | $19.98 | 2025 | Gvoke Hypopen |
| Ibsa Pharma INC. | $18.93 | 2025 | Licart, Flector, Tirosint |
| Exact Sciences Corporation | $18.16 | 2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $14.56 | 2025 | Nexletol |
| Novo Nordisk INC | $13.80 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.